Adaptimmune to Host Virtual Investor Day on Friday, November 20th

NEXT STORY
eFFECTOR Announces Dosing of First Breast Cancer Patient with Tomivosertib in Combination with Chemotherapy Through a Grant from Stand Up To Cancer® (SU2C) Canada
PREV STORY
Translate Bio to Participate in Upcoming Investor Conferences
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Tempest Presents Data Supporting the Dual Mechanism of TPST-1495 as an Optimal Approach for Targeting the Prostaglandin Pathway in Cancer

author_avatar
NASDAQ Market News

Orion acquires sales and distribution rights for certain European Countries for Parkinson’s disease drug Stalevo

ORION CORPORATION              PRESS RELEASE           4 DECEMBER  2018 at 15.00 EET Orion acquires sales ...

author_avatar
NASDAQ Market News

Global Pediatric Vaccines Market (2020 to 2030) – COVID-19 Impact and Recovery

author_avatar
NASDAQ Market News